Skip to main content
. 2014 Jan;99(1):111–115. doi: 10.3324/haematol.2013.085811

Figure 2.

Figure 2.

Disease-free (A) and overall (B) survival, stratified by minimal residual disease (MRD) at Day +120 following autologous stem cell transplant (SCT); MRD ≤0.001 (major molecular response) versus >0.001 (lack of major molecular response).